Expanding the Terpene Universe: Synthetic Biology and Non-Natural Chemistry in Engineered Microorganisms. [PDF]
Hu Y +6 more
europepmc +1 more source
Activity-based probes and chemical proteomics uncover the biological impact of targeting HMG-CoA Synthase 1 in the mevalonate pathway. [PDF]
Yi SA +5 more
europepmc +1 more source
Lipids Metabolism Inhibition Antiproliferative Synergy with 5-Fluorouracil in Human Colorectal Cancer Model. [PDF]
Zabielska J +4 more
europepmc +1 more source
Tumor Cholesterol Synthesis, Statin Use, and Lethal Prostate Cancer. [PDF]
Flanagan S +14 more
europepmc +1 more source
Mendelian randomization analysis of lipid-lowering drug targets and neuropsychiatric disorders. [PDF]
Peng S, Liu M, Du F, Li K.
europepmc +1 more source
Lipid liquid-crystalline nanoparticles as a suitable platform for accommodating sensitive membrane proteins: monitoring the activity of HMG-CoA reductase. [PDF]
Zaborowska-Mazurkiewicz M +2 more
europepmc +1 more source
Causal Association Between Cholesterol-Lowering Drugs and Diabetic Microvascular Complications: A Drug-Target Mendelian Randomization Study. [PDF]
Yang B +5 more
europepmc +1 more source
Computational identification of epifriedelanol and derived analogs from Mikania cordata as potential HMG-CoA reductase inhibitors. [PDF]
Banu M, Ahmed SS, Begum M, Rahman MO.
europepmc +1 more source
HMGCR genetic variability in Parkinson's disease in a Spanish cohort: associations with lipid metabolism and early onset. [PDF]
Díaz-Belloso R +13 more
europepmc +1 more source
Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: A drug-target Mendelian randomization study. [PDF]
Li M +7 more
europepmc +1 more source

